GB/T 16886.11-2021 PDF EnglishUS$440.00 · In stock · Download in 9 seconds
GB/T 16886.11-2021: Biological evaluation of medical devices - Part 11: Tests for systemic toxicity Delivery: 9 seconds. True-PDF full-copy in English & invoice will be downloaded + auto-delivered via email. See step-by-step procedure Status: Valid GB/T 16886.11: Historical versions
Similar standardsGB/T 16886.11-2021: Biological evaluation of medical devices - Part 11: Tests for systemic toxicity---This is an excerpt. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.), auto-downloaded/delivered in 9 seconds, can be purchased online: https://www.ChineseStandard.net/PDF.aspx/GBT16886.11-2021NATIONAL STANDARD OF THE PEOPLE’S REPUBLIC OF CHINA ICS 11.100.20 CCS C 30 GB/T 16886.11-2021 / ISO 10993-11.2017 Replacing GB/T 16886.11-2011 Biological evaluation of medical devices - Part 11.Tests for systemic toxicity (ISO 10993-11.2017, IDT) Issued on. NOVEMBER 26, 2021 Implemented on. DECEMBER 01, 2022 Issued by. State Administration for Market Regulation; Standardization Administration of the PRC. Table of ContentsForeword... 4 Introduction... 6 1 Scope... 9 2 Normative references... 9 3 Terms and definitions... 9 4 General considerations... 11 4.1 General... 11 4.2 Selection of animal species... 12 4.3 Animal status... 12 4.4 Animal care and husbandry... 12 4.5 Size and number of groups... 13 4.5.1 Size of groups... 13 4.5.2 Number of groups... 13 4.5.3 Treatment controls... 14 4.6 Route of exposure... 14 4.7 Sample preparation... 14 4.8 Dosing... 14 4.8.1 Test sample administration... 14 4.8.2 Dosage volumes... 15 4.8.3 Dosage frequency... 15 4.9 Body weight and food/water consumption... 16 4.10 Clinical observations... 16 4.11 Clinical pathology... 16 4.12 Anatomic pathology... 17 4.13 Study designs... 17 4.14 Quality of investigation... 17 5 Acute systemic toxicity... 18 5.1 General... 18 5.2 Study design... 18 5.2.1 Preparations... 18 5.2.2 Experimental animals... 18 5.2.3 Test conditions... 19 5.2.4 Body weights... 19 5.2.5 Clinical observations... 19 5.2.6 Pathology... 20 5.3 Evaluation criteria... 21 5.3.1 General... 21 5.3.2 Evaluation of results... 21 5.4 Final report... 22 6 Repeated exposure systemic toxicity (subacute, subchronic and chronic systemic toxicity)... 23 6.1 General... 23 6.2 Study design... 24 6.2.1 Preparations... 24 6.2.2 Experimental animals... 24 6.2.3 Test conditions... 25 6.2.4 Body weights... 25 6.2.5 Clinical observations... 25 6.2.6 Pathology... 26 6.3 Evaluation criteria... 27 6.3.1 General... 27 6.3.2 Evaluation of results... 27 6.4 Final report... 28 Annex A (Informative) Routes of administration... 29 Annex B (Informative) Dosage volumes... 32 Annex C (Informative) Common clinical signs and observations... 33 Annex D (Informative) Suggested haematology, clinical chemistry and urinalysis measurements... 34 Annex E (Informative) Suggested organ list for histopathological evaluation... 36 Annex F (Informative) Organ list for limited histopathology for medical devices subjected to systemic toxicity testing... 39 Annex G (Informative) Information on material-mediated pyrogens... 41 Annex H (Informative) Subchronic rat systemic toxicity - Dual routes of parenteral administration... 43 Bibliography... 45ForewordThis document is drafted in accordance with GB/T 1.1-2020 "Directives for standardization - Part 1.Rules for the structure and drafting of standardizing documents". The document is Part 11 of GB/T 16886 "Biological evaluation of medical devices". GB/T 16886 has issued the following parts. - Part 1.Evaluation and testing within a risk management process; - Part 2.Animal welfare requirements; - Part 3.Tests for genotoxicity, carcinogenicity and reproductive toxicity; - Part 4.Selection of tests for interactions with blood; - Part 5.Tests for in vitro cytotoxicity; - Part 6.Tests for local effects after implantation; - Part 7.Ethylene oxide sterilization residuals; - Part 9.Framework for identification and quantification of potential degradation products; - Part 10.Tests for irritation and skin sensitization; - Part 11.Tests for systemic toxicity; - Part 12.Sample preparation and reference materials; - Part 13.Identification and quantification of degradation products from polymeric medical devices; - Part 14.Identification and quantification of degradation products from ceramics; - Part 15.Identification and quantification of degradation products from metals and alloys; - Part 16.Toxicokinetic study design for degradation products and leachables; - Part 17.Establishment of allowable limits for leachable substances; - Part 18.Chemical characterization of materials; - Part 19.Physico-chemical, morphological and topographical characterization of materials; - Part 20.Principles and methods for immunotoxicology testing of medical devices. This document replaces GB/T 16886.11-2011 "Biological evaluation of medical devices - Part 11.Tests for systemic toxicity". Compared with GB/T 16886.11-2011, the main technical change is as follows. - Modify the size of groups for chronic toxicity tests (see Table 1; Table 1 of the 2011 edition). This document, using translation method, is identical to ISO 10993-11.2017 "Biological evaluation of medical devices - Part 11.Tests for systemic toxicity". China’s documents which have a consistent correspondence with the international documents normatively referenced in this document are as follows. - GB/T 16886.1-2011 Biological evaluation of medical devices - Part 1.Evaluation and testing within a risk management process (ISO 10993-1.2009, IDT); - GB/T 16886.2-2011 Biological evaluation of medical devices - Part 2.Animal welfare requirements (ISO 10993-2.2006, IDT). Attention is drawn to the possibility that some of the elements of this document may be the subject of patent rights. The issuing authority of this document shall not be held responsible for identifying any or all such patent rights. This document was proposed by National Medical Products Administration. This document shall be under the jurisdiction of National Technical Committee 248 on Biological Evaluation of Medical Devices of Standardization Administration of China (SAC/TC 248). Drafting organizations of this document. Shandong Quality Inspection Center for Medical Devices, National Institutes for Food and Drug Control. Main drafters of this document. Wang Xin, Sun Likui, Han Qianqian, Wang Han, Chu Xiangyu, Xu Jing. The previous releases of this document and the documents it replaces are as follows. - It was first issued in 1997 as GB/T 16886.11-1997 and first revised in 2011; - This is the second revision.1 ScopeThis document specifies requirements and gives guidance on procedures to be followed in the evaluation of the potential for medical device materials to cause adverse systemic reactions.2 Normative referencesThe contents of the following documents, through normative references in this text, constitute indispensable provisions of this document. Among them, for dated references, only the edition corresponding to that date applies to this document. For undated references, the latest edition (including all amendments) applies to this document. ISO 10993-1 Biological evaluation of medical devices - Part 1.Evaluation and testing within a risk management process3 Terms and definitionsFor the purposes of this document, the terms and definitions given in ISO 10993-1 and the following apply. Relationship between the dosage and the magnitude of a defined biological effect either in an individual or in a population sample.4 General considerationsThere is no absolute criterion for selecting a particular animal species for systemic toxicity testing of medical devices. However, the species used shall be scientifically justified and in line with the provisions of ISO 10993-2. Depending on the objective of the study, the nature of the test article and the route of exposure, negative, vehicle and/or sham-treated controls should be incorporated into all systemic toxicity studies.5 Acute systemic toxicityHealthy young adult animals are acclimatized to the laboratory conditions for at least 5 d prior to the test. Shorter durations shall be justified. Animals are then randomized and assigned to the treatment groups. 6 Repeated exposure systemic toxicity (subacute, subchronic and chronic systemic toxicity) The dose to use for toxicity tests of medical devices shall be defined in relation to the results of risk assessment, balancing the clinical exposure dose with the use of safety factors, as applicable. Except for treatment with the test substance, animals in the control group should be handled in an identical manner to the test group subjects. ......Source: Above contents are excerpted from the full-copy PDF -- translated/reviewed by: www.ChineseStandard.net / Wayne Zheng et al. Tips & Frequently Asked Questions:Question 1: How long will the true-PDF of English version of GB/T 16886.11-2021 be delivered?Answer: The full copy PDF of English version of GB/T 16886.11-2021 can be downloaded in 9 seconds, and it will also be emailed to you in 9 seconds (double mechanisms to ensure the delivery reliably), with PDF-invoice.Question 2: Can I share the purchased PDF of GB/T 16886.11-2021_English with my colleagues?Answer: Yes. The purchased PDF of GB/T 16886.11-2021_English will be deemed to be sold to your employer/organization who actually paid for it, including your colleagues and your employer's intranet.Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. www.ChineseStandard.us -- GB/T 16886.11-2021 -- Click this link and select your country/currency to pay, the exact amount in your currency will be printed on the invoice. Full PDF will also be downloaded/emailed in 9 seconds.Question 5: Should I purchase the latest version GB/T 16886.11-2021?Answer: Yes. Unless special scenarios such as technical constraints or academic study, you should always prioritize to purchase the latest version GB/T 16886.11-2021 even if the enforcement date is in future. Complying with the latest version means that, by default, it also complies with all the earlier versions, technically.How to buy and download a true PDF of English version of GB/T 16886.11-2021?A step-by-step guide to download PDF of GB/T 16886.11-2021_EnglishStep 1: Visit website https://www.ChineseStandard.net (Pay in USD), or https://www.ChineseStandard.us (Pay in any currencies such as Euro, KRW, JPY, AUD).Step 2: Search keyword "GB/T 16886.11-2021". Step 3: Click "Add to Cart". If multiple PDFs are required, repeat steps 2 and 3 to add up to 12 PDFs to cart. Step 4: Select payment option (Via payment agents Stripe or PayPal). Step 5: Customize Tax Invoice -- Fill up your email etc. Step 6: Click "Checkout". Step 7: Make payment by credit card, PayPal, Google Pay etc. After the payment is completed and in 9 seconds, you will receive 2 emails attached with the purchased PDFs and PDF-invoice, respectively. Step 8: Optional -- Go to download PDF. Step 9: Optional -- Click Open/Download PDF to download PDFs and invoice. See screenshots for above steps: Steps 1~3 Steps 4~6 Step 7 Step 8 Step 9 |
